$STEP
StepStone Group Inc. Stock $step

$step Overview Financials Valuation SEC Filings Company Website

2023 Q1 Form 10-K Financial Statement

#000179602223000033 Filed on May 26, 2023

Income Statement

Concept	2023 Q1	2023
Revenue	$175.3M	-$67.57M
YoY Change	-49.84%	-104.95%
Cost Of Revenue	$12.76M	$79.85M
YoY Change	-85.8%	-80.24%
Gross Profit	$162.6M	-$149.9M
YoY Change	-37.39%	-115.73%
Gross Profit Margin	92.73%
Selling, General & Admin	$114.9M	$427.0M
YoY Change	27.4%	44.77%
% of Gross Profit	70.69%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$12.13M	$47.44M
YoY Change	3.82%	75.86%
% of Gross Profit	7.46%
Operating Expenses	$168.5M	$307.9M
YoY Change	-8.18%	-39.51%
Operating Profit	-$5.869M	-$457.9M
YoY Change	-107.7%	-203.16%
Interest Expense	$68.99M	$4.189M
YoY Change	244.66%	276.37%
% of Operating Profit
Other Income/Expense, Net	$4.380M	-$40.96M
YoY Change	-77.66%	-168.01%
Pretax Income	$67.51M	-$41.45M
YoY Change	-41.73%	-108.09%
Income Tax	$10.69M	$3.821M
% Of Pretax Income	15.83%
Net Earnings	$28.80M	-$18.40M
YoY Change	-31.12%	-109.49%
Net Earnings / Revenue	16.43%
Basic Earnings Per Share		-$0.30
Diluted Earnings Per Share	$0.44	-$0.30
COMMON SHARES
Basic Shares Outstanding		61.88M shares
Diluted Shares Outstanding		61.88M shares

Balance Sheet

Concept	2023 Q1	2023
SHORT-TERM ASSETS
Cash & Short-Term Investments	$128.6M	$128.6M
YoY Change	10.46%	10.46%
Cash & Equivalents	$129.5M	$128.6M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables	$44.45M	$44.45M
Other Receivables	$2.052B	$2.052B
Total Short-Term Assets	$2.225B	$2.225B
YoY Change	-25.46%	-25.46%
LONG-TERM ASSETS
Property, Plant & Equipment	$15.84M	$101.1M
YoY Change	24.13%	36.98%
Goodwill	$580.5M
YoY Change	0.0%
Intangibles	$354.6M
YoY Change	-10.92%
Long-Term Investments	$2.113B	$145.8M
YoY Change	-27.69%	36.19%
Other Assets	$45.31M	$45.31M
YoY Change	56.64%	56.64%
Total Long-Term Assets	$1.272B	$1.272B
YoY Change	5.74%	5.74%
TOTAL ASSETS
Total Short-Term Assets	$2.225B	$2.225B
Total Long-Term Assets	$1.272B	$1.272B
Total Assets	$3.497B	$3.497B
YoY Change	-16.49%	-16.49%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$89.40M	$89.40M
YoY Change	45.26%	45.26%
Accrued Expenses	$1.450B	$1.450B
YoY Change	-28.24%	-28.24%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$1.745B	$1.745B
YoY Change	-23.52%	-23.52%
LONG-TERM LIABILITIES
Long-Term Debt	$98.35M	$98.35M
YoY Change	56.41%	56.41%
Other Long-Term Liabilities	$566.0K	$566.0K
YoY Change	-97.02%	-97.02%
Total Long-Term Liabilities	$98.92M	$98.92M
YoY Change	20.81%	20.81%
TOTAL LIABILITIES
Total Short-Term Liabilities	$1.745B	$1.745B
Total Long-Term Liabilities	$98.92M	$98.92M
Total Liabilities	$1.844B	$2.726B
YoY Change	-21.99%	-19.13%
SHAREHOLDERS EQUITY
Retained Earnings	$160.4M
YoY Change	-30.13%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$771.6M	$771.6M
YoY Change
Total Liabilities & Shareholders Equity	$3.497B	$3.497B
YoY Change	-16.49%	-16.49%

Cashflow Statement

Concept	2023 Q1	2023
OPERATING ACTIVITIES
Net Income	$28.80M	-$18.40M
YoY Change	-31.12%	-109.49%
Depreciation, Depletion And Amortization	$12.13M	$47.44M
YoY Change	3.82%	75.86%
Cash From Operating Activities	-$516.0K	$151.2M
YoY Change	-101.6%	-29.45%
INVESTING ACTIVITIES
Capital Expenditures	$2.478M	$5.627M
YoY Change	-639.87%	167.57%
Acquisitions		$0.00
YoY Change		-100.0%
Other Investing Activities	-$4.917M	-$1.000K
YoY Change	-40.81%	-97.14%
Cash From Investing Activities	-$7.395M	-$30.81M
YoY Change	-15.64%	-85.35%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-3.369M	-$108.0M
YoY Change	-92.23%	53.35%
NET CHANGE
Cash From Operating Activities	-516.0K	$151.2M
Cash From Investing Activities	-7.395M	-$30.81M
Cash From Financing Activities	-3.369M	-$108.0M
Net Change In Cash	-11.28M	$12.07M
YoY Change	-43.11%	-118.17%
FREE CASH FLOW
Cash From Operating Activities	-$516.0K	$151.2M
Capital Expenditures	$2.478M	$5.627M
Free Cash Flow	-$2.994M	$145.6M
YoY Change	-109.14%	-31.4%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023	dei	Entity Central Index Key EntityCentralIndexKey	0001796022
CY2023	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2023	dei	Amendment Flag AmendmentFlag	false
CY2023	dei	Document Type DocumentType	10-K
CY2023	dei	Document Annual Report DocumentAnnualReport	true
CY2023	dei	Document Period End Date DocumentPeriodEndDate	2023-03-31
CY2023	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--03-31
CY2023	dei	Document Transition Report DocumentTransitionReport	false
CY2023	dei	Entity File Number EntityFileNumber	001-39510
CY2023	dei	Entity Registrant Name EntityRegistrantName	STEPSTONE GROUP INC.
CY2023	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2023	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	84-3868757
CY2023	dei	Entity Address Address Line1 EntityAddressAddressLine1	450 Lexington Avenue
CY2023	dei	Entity Address Address Line2 EntityAddressAddressLine2	31st Floor
CY2023	dei	Entity Address City Or Town EntityAddressCityOrTown	New York
CY2023	dei	Entity Address State Or Province EntityAddressStateOrProvince	NY
CY2023	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	10017
CY2023	dei	City Area Code CityAreaCode	212
CY2023	dei	Local Phone Number LocalPhoneNumber	351-6100
CY2023	dei	Security12b Title Security12bTitle	Class A Common Stock, $0.001 par value per share
CY2023	dei	Trading Symbol TradingSymbol	STEP
CY2023	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2023	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	Yes
CY2023	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2023	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
CY2023	dei	Entity Small Business EntitySmallBusiness	false
CY2023	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	true
CY2023	dei	Entity Shell Company EntityShellCompany	false
CY2022Q3	dei	Entity Public Float EntityPublicFloat	1195500000	usd
CY2023	dei	Auditor Firm AuditorFirmId	42
CY2023	dei	Auditor Name AuditorName	Ernst & Young LLP
CY2023	dei	Auditor Location AuditorLocation	Los Angeles, CA
CY2023Q1	us-gaap	Restricted Cash RestrictedCash	955000	usd
CY2022Q1	us-gaap	Restricted Cash RestrictedCash	1063000	usd
CY2023Q1	us-gaap	Accounts Receivable Net AccountsReceivableNet	44450000	usd
CY2022Q1	us-gaap	Accounts Receivable Net AccountsReceivableNet	34141000	usd
CY2023Q1	us-gaap	Due From Related Parties DueFromRelatedParties	54322000	usd
CY2022Q1	us-gaap	Due From Related Parties DueFromRelatedParties	19369000	usd
CY2023Q1	step	Equity Method Investments Excluding Accrued Carried Interest Allocations EquityMethodInvestmentsExcludingAccruedCarriedInterestAllocations	115187000	usd
CY2022Q1	step	Equity Method Investments Excluding Accrued Carried Interest Allocations EquityMethodInvestmentsExcludingAccruedCarriedInterestAllocations	107045000	usd
CY2023Q1	step	Equity Method Investments Accrued Carried Interest Allocations EquityMethodInvestmentsAccruedCarriedInterestAllocations	1227173000	usd
CY2022Q1	step	Equity Method Investments Accrued Carried Interest Allocations EquityMethodInvestmentsAccruedCarriedInterestAllocations	1480515000	usd
CY2023Q1	step	Legacy Investments In Funds And Accrued Carried Interest Allocations LegacyInvestmentsInFundsAndAccruedCarriedInterestAllocations	770652000	usd
CY2022Q1	step	Legacy Investments In Funds And Accrued Carried Interest Allocations LegacyInvestmentsInFundsAndAccruedCarriedInterestAllocations	1334581000	usd
CY2023Q1	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	44358000	usd
CY2022Q1	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	27866000	usd
CY2023Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	101130000	usd
CY2022Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	61065000	usd
CY2023Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	354645000	usd
CY2022Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	398126000	usd
CY2023Q1	us-gaap	Goodwill Goodwill	580542000	usd
CY2022Q1	us-gaap	Goodwill Goodwill	580542000	usd
CY2023Q1	us-gaap	Assets Assets	3497403000	usd
CY2022Q1	us-gaap	Assets Assets	4188125000	usd
CY2023Q1	us-gaap	Employee Related Liabilities Current And Noncurrent EmployeeRelatedLiabilitiesCurrentAndNoncurrent	66614000	usd
CY2022Q1	us-gaap	Employee Related Liabilities Current And Noncurrent EmployeeRelatedLiabilitiesCurrentAndNoncurrent	46397000	usd
CY2023Q1	step	Equity Method Investment Accrued Carried Interest Related Compensation Payable EquityMethodInvestmentAccruedCarriedInterestRelatedCompensationPayable	644517000	usd
CY2022Q1	step	Equity Method Investment Accrued Carried Interest Related Compensation Payable EquityMethodInvestmentAccruedCarriedInterestRelatedCompensationPayable	763557000	usd
CY2023Q1	step	Legacy Investment Accrued Carried Interest Related Compensation Payable LegacyInvestmentAccruedCarriedInterestRelatedCompensationPayable	617994000	usd
CY2022Q1	step	Legacy Investment Accrued Carried Interest Related Compensation Payable LegacyInvestmentAccruedCarriedInterestRelatedCompensationPayable	1140101000	usd
CY2023Q1	us-gaap	Due To Related Parties Current And Noncurrent DueToRelatedPartiesCurrentAndNoncurrent	205424000	usd
CY2022Q1	us-gaap	Due To Related Parties Current And Noncurrent DueToRelatedPartiesCurrentAndNoncurrent	199355000	usd
CY2023Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	121224000	usd
CY2022Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	70965000	usd
CY2023Q1	us-gaap	Long Term Debt LongTermDebt	98351000	usd
CY2022Q1	us-gaap	Long Term Debt LongTermDebt	62879000	usd
CY2023Q1	us-gaap	Liabilities Liabilities	1844086000	usd
CY2022Q1	us-gaap	Liabilities Liabilities	2363795000	usd
CY2023Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q1	us-gaap	Redeemable Noncontrolling Interest Equity Carrying Amount RedeemableNoncontrollingInterestEquityCarryingAmount	24530000	usd
CY2022Q1	us-gaap	Redeemable Noncontrolling Interest Equity Carrying Amount RedeemableNoncontrollingInterestEquityCarryingAmount	0	usd
CY2023Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	610567000	usd
CY2022Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	587243000	usd
CY2023Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	160430000	usd
CY2022Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	229615000	usd
CY2023Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	461000	usd
CY2022Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	658000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	771567000	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	817625000	usd
CY2023Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1628787000	usd
CY2022Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1824330000	usd
CY2023Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	3497403000	usd
CY2022Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	4188125000	usd
CY2023	us-gaap	Revenues Revenues	-67574000	usd
CY2022	us-gaap	Revenues Revenues	1365525000	usd
CY2021	us-gaap	Revenues Revenues	787716000	usd
CY2023	step	Compensation Expense Cash Based Compensation And Benefits CompensationExpenseCashBasedCompensationAndBenefits	252180000	usd
CY2022	step	Compensation Expense Cash Based Compensation And Benefits CompensationExpenseCashBasedCompensationAndBenefits	197482000	usd
CY2021	step	Compensation Expense Cash Based Compensation And Benefits CompensationExpenseCashBasedCompensationAndBenefits	157123000	usd
CY2023	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	24940000	usd
CY2022	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	13996000	usd
CY2021	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	7899000	usd
CY2023	step	Performance Fee Related Compensation Related To Carried Interest Allocation Realized PerformanceFeeRelatedCompensationRelatedToCarriedInterestAllocationRealized	79846000	usd
CY2022	step	Performance Fee Related Compensation Related To Carried Interest Allocation Realized PerformanceFeeRelatedCompensationRelatedToCarriedInterestAllocationRealized	91208000	usd
CY2021	step	Performance Fee Related Compensation Related To Carried Interest Allocation Realized PerformanceFeeRelatedCompensationRelatedToCarriedInterestAllocationRealized	30532000	usd
CY2023	step	Performance Fee Related Compensation Related To Carried Interest Allocation Unrealized PerformanceFeeRelatedCompensationRelatedToCarriedInterestAllocationUnrealized	-119039000	usd
CY2022	step	Performance Fee Related Compensation Related To Carried Interest Allocation Unrealized PerformanceFeeRelatedCompensationRelatedToCarriedInterestAllocationUnrealized	312903000	usd
CY2021	step	Performance Fee Related Compensation Related To Carried Interest Allocation Unrealized PerformanceFeeRelatedCompensationRelatedToCarriedInterestAllocationUnrealized	215508000	usd
CY2023	step	Performance Fee Related Compensation Related To Carried Interest Allocation PerformanceFeeRelatedCompensationRelatedToCarriedInterestAllocation	-39193000	usd
CY2022	step	Performance Fee Related Compensation Related To Carried Interest Allocation PerformanceFeeRelatedCompensationRelatedToCarriedInterestAllocation	404111000	usd
CY2021	step	Performance Fee Related Compensation Related To Carried Interest Allocation PerformanceFeeRelatedCompensationRelatedToCarriedInterestAllocation	246040000	usd
CY2023	step	Legacy Performance Fee Related Compensation Related To Carried Interest Allocation LegacyPerformanceFeeRelatedCompensationRelatedToCarriedInterestAllocation	-452163000	usd
CY2022	step	Legacy Performance Fee Related Compensation Related To Carried Interest Allocation LegacyPerformanceFeeRelatedCompensationRelatedToCarriedInterestAllocation	187106000	usd
CY2021	step	Legacy Performance Fee Related Compensation Related To Carried Interest Allocation LegacyPerformanceFeeRelatedCompensationRelatedToCarriedInterestAllocation	0	usd
CY2023	step	Compensation And Benefits Expense CompensationAndBenefitsExpense	-214236000	usd
CY2022	step	Compensation And Benefits Expense CompensationAndBenefitsExpense	802695000	usd
CY2021	step	Compensation And Benefits Expense CompensationAndBenefitsExpense	411062000	usd
CY2023	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	147159000	usd
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	110468000	usd
CY2021	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	48485000	usd
CY2023	us-gaap	Costs And Expenses CostsAndExpenses	-67077000	usd
CY2022	us-gaap	Costs And Expenses CostsAndExpenses	913163000	usd
CY2021	us-gaap	Costs And Expenses CostsAndExpenses	459547000	usd
CY2023	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-2509000	usd
CY2022	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	26160000	usd
CY2021	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	16407000	usd
CY2023	step	Legacy Investment Income LegacyInvestmentIncome	-44075000	usd
CY2022	step	Legacy Investment Income LegacyInvestmentIncome	32586000	usd
CY2021	step	Legacy Investment Income LegacyInvestmentIncome	0	usd
CY2023	step	Income Loss From Consolidated Funds IncomeLossFromConsolidatedFunds	9315000	usd
CY2022	step	Income Loss From Consolidated Funds IncomeLossFromConsolidatedFunds	0	usd
CY2021	step	Income Loss From Consolidated Funds IncomeLossFromConsolidatedFunds	0	usd
CY2023	us-gaap	Investment Income Interest InvestmentIncomeInterest	1921000	usd
CY2022	us-gaap	Investment Income Interest InvestmentIncomeInterest	337000	usd
CY2021	us-gaap	Investment Income Interest InvestmentIncomeInterest	413000	usd
CY2023	us-gaap	Interest Expense InterestExpense	4189000	usd
CY2022	us-gaap	Interest Expense InterestExpense	1113000	usd
CY2021	us-gaap	Interest Expense InterestExpense	7360000	usd
CY2023	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-1420000	usd
CY2022	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	2249000	usd
CY2021	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	220000	usd
CY2023	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-40957000	usd
CY2022	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	60219000	usd
CY2021	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	9680000	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-41454000	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	512581000	usd
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	337849000	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	3821000	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	28300000	usd
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	23256000	usd
CY2023	us-gaap	Profit Loss ProfitLoss	-45275000	usd
CY2022	us-gaap	Profit Loss ProfitLoss	484281000	usd
CY2021	us-gaap	Profit Loss ProfitLoss	314593000	usd
CY2023	us-gaap	Net Income Loss Attributable To Redeemable Noncontrolling Interest NetIncomeLossAttributableToRedeemableNoncontrollingInterest	1776000	usd
CY2022	us-gaap	Net Income Loss Attributable To Redeemable Noncontrolling Interest NetIncomeLossAttributableToRedeemableNoncontrollingInterest	0	usd
CY2021	us-gaap	Net Income Loss Attributable To Redeemable Noncontrolling Interest NetIncomeLossAttributableToRedeemableNoncontrollingInterest	0	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-18398000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	193885000	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	62634000	usd
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.30
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	3.89
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	2.11
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.30
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	3.84
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	2.06
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	61884671	shares
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	49833760	shares
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	29657805	shares
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	61884671	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	53600250	shares
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	33274804	shares
CY2023	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.80
CY2022	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.44
CY2021	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.07
CY2023	us-gaap	Profit Loss ProfitLoss	-45275000	usd
CY2022	us-gaap	Profit Loss ProfitLoss	484281000	usd
CY2021	us-gaap	Profit Loss ProfitLoss	314593000	usd
CY2023	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-181000	usd
CY2022	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	329000	usd
CY2021	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	1619000	usd
CY2023	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax	506000	usd
CY2022	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax	-1365000	usd
CY2021	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax	244000	usd
CY2023	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-687000	usd
CY2022	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	1694000	usd
CY2021	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	1375000	usd
CY2023	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-45962000	usd
CY2022	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	485975000	usd
CY2021	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	315968000	usd
CY2023	step	Comprehensive Income Loss Net Of Tax Redeemable Noncontrolling Interest ComprehensiveIncomeLossNetOfTaxRedeemableNoncontrollingInterest	1776000	usd
CY2022	step	Comprehensive Income Loss Net Of Tax Redeemable Noncontrolling Interest ComprehensiveIncomeLossNetOfTaxRedeemableNoncontrollingInterest	0	usd
CY2021	step	Comprehensive Income Loss Net Of Tax Redeemable Noncontrolling Interest ComprehensiveIncomeLossNetOfTaxRedeemableNoncontrollingInterest	0	usd
CY2023	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-18594000	usd
CY2022	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	194334000	usd
CY2021	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	62752000	usd
CY2020Q1	us-gaap	Partners Capital Including Portion Attributable To Noncontrolling Interest PartnersCapitalIncludingPortionAttributableToNoncontrollingInterest	236967000	usd
	us-gaap	Net Income Loss Including Portion Attributable To Nonredeemable Noncontrolling Interest NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest	57693000	usd
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	685000	usd
	us-gaap	Partners Capital Account Contributions PartnersCapitalAccountContributions	27000	usd
	us-gaap	Partners Capital Account Unit Based Compensation PartnersCapitalAccountUnitBasedCompensation	725000	usd
	us-gaap	Partners Capital Account Sale Of Units PartnersCapitalAccountSaleOfUnits	3308000	usd
	us-gaap	Partners Capital Account Treasury Units Purchases PartnersCapitalAccountTreasuryUnitsPurchases	3308000	usd
	us-gaap	Partners Capital Account Distributions PartnersCapitalAccountDistributions	63585000	usd
	step	Partners Capital Account Reallocation Between Controlling And Non Controlling Interest PartnersCapitalAccountReallocationBetweenControllingAndNonControllingInterest	0	usd
	step	Stockholders Equity Effect Of Reorganization StockholdersEquityEffectOfReorganization	0	usd
	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	337798000	usd
	step	Adjustments To Additional Paid In Capital Purchase Of Partnership Interests AdjustmentsToAdditionalPaidInCapitalPurchaseOfPartnershipInterests	127986000	usd
	us-gaap	Profit Loss ProfitLoss	256900000	usd
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	690000	usd
	step	Noncontrolling Interest Increase From Contributions NoncontrollingInterestIncreaseFromContributions	2749000	usd
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	7174000	usd
	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	34091000	usd
	us-gaap	Dividends Dividends	2227000	usd
	step	Stock Issued During Period Value Exchange Of Securities And New Issues StockIssuedDuringPeriodValueExchangeOfSecuritiesAndNewIssues	-9000	usd
	us-gaap	Adjustments To Additional Paid In Capital Stock Issued Issuance Costs AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts	11221000	usd
	step	Partners Capital Account Reallocation Between Controlling And Non Controlling Interest PartnersCapitalAccountReallocationBetweenControllingAndNonControllingInterest	0	usd
	step	Adjustments To Additional Paid In Capital Deferred Tax Effect AdjustmentsToAdditionalPaidInCapitalDeferredTaxEffect	2596000	usd
CY2021Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	659693000	usd
CY2021Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	659693000	usd
CY2022	us-gaap	Net Income Loss Including Portion Attributable To Nonredeemable Noncontrolling Interest NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest	484281000	usd
CY2022	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	1694000	usd
CY2022	step	Noncontrolling Interest Increase From Contributions NoncontrollingInterestIncreaseFromContributions	15161000	usd
CY2022	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	13996000	usd
CY2022	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	118796000	usd
CY2022	us-gaap	Minority Interest Decrease From Redemptions MinorityInterestDecreaseFromRedemptions	3046000	usd
CY2022	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	24677000	usd
CY2022	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross	0	usd
CY2022	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	-9000	usd
CY2022	us-gaap	Noncontrolling Interest Increase From Business Combination NoncontrollingInterestIncreaseFromBusinessCombination	158142000	usd
CY2022	us-gaap	Adjustments To Additional Paid In Capital Stock Issued Issuance Costs AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts	653000	usd
CY2022	step	Adjustments To Additional Paid In Capital Reallocation Of Noncontrolling Interest AdjustmentsToAdditionalPaidInCapitalReallocationOfNoncontrollingInterest	0	usd
CY2022	step	Adjustments To Additional Paid In Capital Deferred Tax Effect Of Exchange AdjustmentsToAdditionalPaidInCapitalDeferredTaxEffectOfExchange	55293000	usd
CY2022Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1824330000	usd
CY2023	us-gaap	Net Income Loss Including Portion Attributable To Nonredeemable Noncontrolling Interest NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest	-47051000	usd
CY2023	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-687000	usd
CY2023	step	Noncontrolling Interest Increase From Contributions NoncontrollingInterestIncreaseFromContributions	13566000	usd
CY2023	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	16389000	usd
CY2023	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	120643000	usd
CY2023	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	50787000	usd
CY2023	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross	-2743000	usd
CY2023	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	-1000	usd
CY2023	step	Adjustments To Additional Paid In Capital Reallocation Of Noncontrolling Interest AdjustmentsToAdditionalPaidInCapitalReallocationOfNoncontrollingInterest	0	usd
CY2023	step	Adjustments To Additional Paid In Capital Deferred Tax Effect Of Exchange AdjustmentsToAdditionalPaidInCapitalDeferredTaxEffectOfExchange	3586000	usd
CY2023Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1628787000	usd
CY2023	us-gaap	Profit Loss ProfitLoss	-45275000	usd
CY2022	us-gaap	Profit Loss ProfitLoss	484281000	usd
CY2021	us-gaap	Profit Loss ProfitLoss	314593000	usd
CY2023	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	47443000	usd
CY2022	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	26977000	usd
CY2021	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	5495000	usd
CY2023	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	472000	usd
CY2022	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	236000	usd
CY2021	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	3856000	usd
CY2023	us-gaap	Share Based Compensation ShareBasedCompensation	24940000	usd
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	13996000	usd
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	7899000	usd
CY2023	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	-12692000	usd
CY2022	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	6216000	usd
CY2021	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	15913000	usd
CY2023	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	9361000	usd
CY2022	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	9600000	usd
CY2021	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	1608000	usd
CY2023	step	Gain Loss On Remeasurement Of Lease Liabilities GainLossOnRemeasurementOfLeaseLiabilities	2709000	usd
CY2022	step	Gain Loss On Remeasurement Of Lease Liabilities GainLossOnRemeasurementOfLeaseLiabilities	0	usd
CY2021	step	Gain Loss On Remeasurement Of Lease Liabilities GainLossOnRemeasurementOfLeaseLiabilities	0	usd
CY2023	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-40000	usd
CY2022	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	3034000	usd
CY2021	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-70000	usd
CY2023	step	Unrealized Income Loss From Consolidated Funds UnrealizedIncomeLossFromConsolidatedFunds	9312000	usd
CY2022	step	Unrealized Income Loss From Consolidated Funds UnrealizedIncomeLossFromConsolidatedFunds	0	usd
CY2021	step	Unrealized Income Loss From Consolidated Funds UnrealizedIncomeLossFromConsolidatedFunds	0	usd
CY2023	step	Payments To Acquire Consolidated Funds PaymentsToAcquireConsolidatedFunds	21287000	usd
CY2022	step	Payments To Acquire Consolidated Funds PaymentsToAcquireConsolidatedFunds	0	usd
CY2021	step	Payments To Acquire Consolidated Funds PaymentsToAcquireConsolidatedFunds	0	usd
CY2023	step	Proceeds From Sale Of Consolidated Funds ProceedsFromSaleOfConsolidatedFunds	4000	usd
CY2022	step	Proceeds From Sale Of Consolidated Funds ProceedsFromSaleOfConsolidatedFunds	0	usd
CY2021	step	Proceeds From Sale Of Consolidated Funds ProceedsFromSaleOfConsolidatedFunds	0	usd
CY2023	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	10309000	usd
CY2022	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	1774000	usd
CY2021	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	6975000	usd
CY2023	us-gaap	Increase Decrease In Due From Related Parties IncreaseDecreaseInDueFromRelatedParties	30222000	usd
CY2022	us-gaap	Increase Decrease In Due From Related Parties IncreaseDecreaseInDueFromRelatedParties	11490000	usd
CY2021	us-gaap	Increase Decrease In Due From Related Parties IncreaseDecreaseInDueFromRelatedParties	-2216000	usd
CY2023	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	-1216000	usd
CY2022	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	6663000	usd
CY2021	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	9767000	usd
CY2023	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	11160000	usd
CY2022	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	-1445000	usd
CY2021	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	23439000	usd
CY2023	us-gaap	Increase Decrease In Due To Related Parties IncreaseDecreaseInDueToRelatedParties	-765000	usd
CY2022	us-gaap	Increase Decrease In Due To Related Parties IncreaseDecreaseInDueToRelatedParties	-2259000	usd
CY2021	us-gaap	Increase Decrease In Due To Related Parties IncreaseDecreaseInDueToRelatedParties	872000	usd
CY2023	step	Increase Decrease In Lease Right Of Use Assets Net Of Lease Liabilities IncreaseDecreaseInLeaseRightOfUseAssetsNetOfLeaseLiabilities	2006000	usd
CY2022	step	Increase Decrease In Lease Right Of Use Assets Net Of Lease Liabilities IncreaseDecreaseInLeaseRightOfUseAssetsNetOfLeaseLiabilities	-413000	usd
CY2021	step	Increase Decrease In Lease Right Of Use Assets Net Of Lease Liabilities IncreaseDecreaseInLeaseRightOfUseAssetsNetOfLeaseLiabilities	0	usd
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	151183000	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	214281000	usd
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	149299000	usd
CY2023	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	0	usd
CY2022	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	181529000	usd
CY2021	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	0	usd
CY2023	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	5627000	usd
CY2022	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	2103000	usd
CY2021	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1258000	usd
CY2023	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	-1000	usd
CY2022	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	-35000	usd
CY2021	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	-7000	usd
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-30807000	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-210241000	usd
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-11166000	usd
CY2023	us-gaap	Proceeds From Partnership Contribution ProceedsFromPartnershipContribution	179000	usd
CY2022	us-gaap	Proceeds From Partnership Contribution ProceedsFromPartnershipContribution	83000	usd
CY2021	us-gaap	Proceeds From Partnership Contribution ProceedsFromPartnershipContribution	2776000	usd
CY2023	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering	0	usd
CY2022	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering	0	usd
CY2021	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering	337798000	usd
CY2023	us-gaap	Proceeds From Long Term Lines Of Credit ProceedsFromLongTermLinesOfCredit	35000000	usd
CY2022	us-gaap	Proceeds From Long Term Lines Of Credit ProceedsFromLongTermLinesOfCredit	185000000	usd
CY2021	us-gaap	Proceeds From Long Term Lines Of Credit ProceedsFromLongTermLinesOfCredit	0	usd
CY2023	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	0	usd
CY2022	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	2356000	usd
CY2021	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	0	usd
CY2023	us-gaap	Payments To Minority Shareholders PaymentsToMinorityShareholders	0	usd
CY2022	us-gaap	Payments To Minority Shareholders PaymentsToMinorityShareholders	3046000	usd
CY2021	us-gaap	Payments To Minority Shareholders PaymentsToMinorityShareholders	131294000	usd
CY2023	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	0	usd
CY2022	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	1732000	usd
CY2021	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	10142000	usd
CY2023	us-gaap	Repayments Of Other Long Term Debt RepaymentsOfOtherLongTermDebt	0	usd
CY2022	us-gaap	Repayments Of Other Long Term Debt RepaymentsOfOtherLongTermDebt	0	usd
CY2021	us-gaap	Repayments Of Other Long Term Debt RepaymentsOfOtherLongTermDebt	147000000	usd
CY2023	us-gaap	Repayments Of Long Term Lines Of Credit RepaymentsOfLongTermLinesOfCredit	0	usd
CY2022	us-gaap	Repayments Of Long Term Lines Of Credit RepaymentsOfLongTermLinesOfCredit	120000000	usd
CY2021	us-gaap	Repayments Of Long Term Lines Of Credit RepaymentsOfLongTermLinesOfCredit	0	usd
CY2023	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	49973000	usd
CY2022	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	23874000	usd
CY2021	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	2047000	usd
CY2023	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	2743000	usd
CY2022	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	0	usd
CY2021	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	0	usd
CY2023	step	Payments To Related Parties Tax Receivable Agreements PaymentsToRelatedPartiesTaxReceivableAgreements	5981000	usd
CY2022	step	Payments To Related Parties Tax Receivable Agreements PaymentsToRelatedPartiesTaxReceivableAgreements	787000	usd
CY2021	step	Payments To Related Parties Tax Receivable Agreements PaymentsToRelatedPartiesTaxReceivableAgreements	0	usd
CY2023	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	-1000	usd
CY2022	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	-9000	usd
CY2021	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	-1029000	usd
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-108021000	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-70439000	usd
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-45306000	usd
CY2023	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-287000	usd
CY2022	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-15000	usd
CY2021	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1097000	usd
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	12068000	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-66414000	usd
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	93924000	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	117449000	usd
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	183863000	usd
CY2020Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	89939000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	129517000	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	117449000	usd
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	183863000	usd
CY2023	us-gaap	Interest Paid Net InterestPaidNet	3551000	usd
CY2022	us-gaap	Interest Paid Net InterestPaidNet	829000	usd
CY2021	us-gaap	Interest Paid Net InterestPaidNet	3491000	usd
CY2023	us-gaap	Income Taxes Paid IncomeTaxesPaid	29487000	usd
CY2022	us-gaap	Income Taxes Paid IncomeTaxesPaid	11688000	usd
CY2021	us-gaap	Income Taxes Paid IncomeTaxesPaid	3413000	usd
CY2023	step	Dividends Incurred But Not Yet Paid DividendsIncurredButNotYetPaid	814000	usd
CY2022	step	Dividends Incurred But Not Yet Paid DividendsIncurredButNotYetPaid	803000	usd
CY2021	step	Dividends Incurred But Not Yet Paid DividendsIncurredButNotYetPaid	180000	usd
CY2023	step	Deferred Tax Effect From Exchange Of Units Net DeferredTaxEffectFromExchangeOfUnitsNet	-3586000	usd
CY2022	step	Deferred Tax Effect From Exchange Of Units Net DeferredTaxEffectFromExchangeOfUnitsNet	-55293000	usd
CY2021	step	Deferred Tax Effect From Exchange Of Units Net DeferredTaxEffectFromExchangeOfUnitsNet	-2596000	usd
CY2023	step	Offering Costs Incurred But Not Yet Paid OfferingCostsIncurredButNotYetPaid	0	usd
CY2022	step	Offering Costs Incurred But Not Yet Paid OfferingCostsIncurredButNotYetPaid	0	usd
CY2021	step	Offering Costs Incurred But Not Yet Paid OfferingCostsIncurredButNotYetPaid	1079000	usd
CY2023	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	77347000	usd
CY2022	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	79688000	usd
CY2021	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	0	usd
CY2023	step	Remeasurement Of Lease Liabilities RemeasurementOfLeaseLiabilities	-18166000	usd
CY2022	step	Remeasurement Of Lease Liabilities RemeasurementOfLeaseLiabilities	0	usd
CY2021	step	Remeasurement Of Lease Liabilities RemeasurementOfLeaseLiabilities	0	usd
CY2023	step	Stock Issued For Acquisitions StockIssuedForAcquisitions	0	usd
CY2022	step	Stock Issued For Acquisitions StockIssuedForAcquisitions	558598000	usd
CY2021	step	Stock Issued For Acquisitions StockIssuedForAcquisitions	0	usd
CY2023	step	Partnership Units Issued For Acquisition PartnershipUnitsIssuedForAcquisition	0	usd
CY2022	step	Partnership Units Issued For Acquisition PartnershipUnitsIssuedForAcquisition	135239000	usd
CY2021	step	Partnership Units Issued For Acquisition PartnershipUnitsIssuedForAcquisition	0	usd
CY2023Q1	us-gaap	Restricted Cash RestrictedCash	955000	usd
CY2022Q1	us-gaap	Restricted Cash RestrictedCash	1063000	usd
CY2021Q1	us-gaap	Restricted Cash RestrictedCash	3977000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	129517000	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	117449000	usd
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	183863000	usd
CY2020Q3	us-gaap	Stock Redeemed Or Called During Period Shares StockRedeemedOrCalledDuringPeriodShares	100	shares
CY2021	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	0	usd
CY2023	us-gaap	Use Of Estimates UseOfEstimates	<div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The preparation of consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes. Management’s estimates and assumptions are based on historical experience and other factors, and these estimates and assumptions require management to exercise judgment in the process of applying the Company’s accounting policies. Factors that may affect or influence management’s estimates and assumptions could include expectations related to future events that management has deemed reasonable under the circumstances. Assumptions and estimates related to the valuation of investments, which directly affect carried interest allocations, carried interest related compensation, and the carrying amount of the Company’s equity in affiliated companies, involve a higher degree of judgment and complexity, and these assumptions and estimates may significantly affect the consolidated financial statements. Actual results could differ from these estimates and those differences may be material.</span></div>
CY2023	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Reclassifications</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Certain prior year amounts have been reclassified to conform to the current period presentation. Amounts relating to unpaid realized carried interest-related compensation that were previously reported within accrued carried interest-related compensation have been presented within accrued compensation and benefits in the consolidated balance sheets. In addition, payments to related parties under Tax Receivable Agreements has been presented separately within cash flows from financing activities in the consolidated statements of cash flows, and was previously included within due to affiliates within cash flows from operating activities.</span></div>
CY2023	us-gaap	Fiscal Period FiscalPeriod	<div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Accounting for Differing Fiscal Periods</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> </span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The StepStone Funds primarily have a fiscal year end as of December 31. The Company accounts for its investments in the StepStone Funds on a three-month lag due to the timing of receipt of financial information from the investments held by the StepStone Funds. The StepStone Funds primarily invest in private markets funds that generally require at least 90 days following the calendar year end to provide audited financial statements. As a result, the Company uses the December 31 audited financial statements of the StepStone Funds, which reflect the underlying private markets funds as of December 31 to record its investments (including any carried interest allocated by those investments) for its fiscal year-end consolidated financial statements as of March 31. The Company further adjusts the reported carrying values of its investments in the StepStone Funds for its share of capital contributions to and distributions from the StepStone Funds during the three-month lag period.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Company does not account for management and advisory fees or incentive fees on a three-month lag.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">To the extent that management becomes aware of any material events that affect the StepStone Funds during the three-month lag period, the effect of the events would be disclosed in the notes to the consolidated financial statements.</span></div>
CY2023	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	0	usd
CY2021Q1	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	usd
CY2020Q1	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	usd
CY2023	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-1600000	usd
CY2022	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-1100000	usd
CY2021	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	600000	usd
CY2022	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	0	usd
CY2023	step	Revenue From Contract With Customer Incentive Fees As Percentage Of Net Investment Income RevenueFromContractWithCustomerIncentiveFeesAsPercentageOfNetInvestmentIncome	0.15
CY2021	us-gaap	Write Off Of Deferred Debt Issuance Cost WriteOffOfDeferredDebtIssuanceCost	3500000	usd
CY2023	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	1	segment
CY2023	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1	segment
CY2023	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Concentrations of Risk</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Financial instruments that potentially subject the Company to concentrations of credit risk or other risks consist principally of cash, cash equivalents, restricted cash, investments and fees receivable. The majority of the Company’s cash, cash equivalents and restricted cash is held in large, high credit quality financial institutions. Substantially all cash amounts on deposit with these large financial institutions exceeded federally insured limits at March 31, 2023 and 2022. The Company actively monitors its banking relationships and periodically performs an assessment of the financial condition and the reputations of these financial institutions. Based on these results, management believes that the Company’s exposure to credit risk is remote. The concentration of credit risk related to fees receivable is generally reduced by the relatively short payment terms extended to the Company’s clients.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Amounts due to the Company in the form of carried interest allocations, which are reported as a component of investments in the consolidated balance sheets, remain subject to investment performance risk. In certain cases, carried interest allocations that have been distributed to the Company may remain subject to clawback, pursuant to the terms of the governing documents of the related funds. Refer to the discussion of carried interest above in this note 2 for additional details regarding the investment performance and clawback risk associated with carried interest allocations that have been recognized in income by the Company and/or recorded as accrued carried interest allocations in the consolidated balance sheets.</span></div>
CY2023Q1	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	21600000	usd
CY2022Q1	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	19000000	usd
CY2023	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	4900000	usd
CY2023Q1	step	Equity Method Investments Excluding Accrued Carried Interest Allocations EquityMethodInvestmentsExcludingAccruedCarriedInterestAllocations	115187000	usd
CY2022Q1	step	Equity Method Investments Excluding Accrued Carried Interest Allocations EquityMethodInvestmentsExcludingAccruedCarriedInterestAllocations	107045000	usd
CY2023Q1	step	Equity Method Investments Accrued Carried Interest Allocations EquityMethodInvestmentsAccruedCarriedInterestAllocations	1227173000	usd
CY2022Q1	step	Equity Method Investments Accrued Carried Interest Allocations EquityMethodInvestmentsAccruedCarriedInterestAllocations	1480515000	usd
CY2023Q1	step	Legacy Investments In Funds And Accrued Carried Interest Allocations LegacyInvestmentsInFundsAndAccruedCarriedInterestAllocations	770652000	usd
CY2022Q1	step	Legacy Investments In Funds And Accrued Carried Interest Allocations LegacyInvestmentsInFundsAndAccruedCarriedInterestAllocations	1334581000	usd
CY2023Q1	us-gaap	Equity Method Investments EquityMethodInvestments	2113012000	usd
CY2022Q1	us-gaap	Equity Method Investments EquityMethodInvestments	2922141000	usd
CY2023Q1	step	Investment Of Consolidated Funds And Equity Method Investments InvestmentOfConsolidatedFundsAndEquityMethodInvestments	2143607000	usd
CY2022Q1	step	Investment Of Consolidated Funds And Equity Method Investments InvestmentOfConsolidatedFundsAndEquityMethodInvestments	2922141000	usd
CY2023Q1	step	Investment In Fund Before Eliminations InvestmentInFundBeforeEliminations	147500000	usd
CY2023Q1	step	Legacy Investments In Funds LegacyInvestmentsInFunds	152700000	usd
CY2022Q1	step	Legacy Investments In Funds LegacyInvestmentsInFunds	194500000	usd
CY2023Q1	step	Legacy Accrued Carried Interest Allocations LegacyAccruedCarriedInterestAllocations	618000000	usd
CY2022Q1	step	Legacy Accrued Carried Interest Allocations LegacyAccruedCarriedInterestAllocations	1140100000	usd
CY2023	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-2509000	usd
CY2022	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	26160000	usd
CY2021	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	16407000	usd
CY2023	step	Legacy Investment Income LegacyInvestmentIncome	-44075000	usd
CY2022	step	Legacy Investment Income LegacyInvestmentIncome	32586000	usd
CY2021	step	Legacy Investment Income LegacyInvestmentIncome	0	usd
CY2023	step	Revenue Not From Contract With Customer Income Loss From Equity Method Investments And Investment Income RevenueNotFromContractWithCustomerIncomeLossFromEquityMethodInvestmentsAndInvestmentIncome	-621000000	usd
CY2022	step	Revenue Not From Contract With Customer Income Loss From Equity Method Investments And Investment Income RevenueNotFromContractWithCustomerIncomeLossFromEquityMethodInvestmentsAndInvestmentIncome	1032421000	usd
CY2021	step	Revenue Not From Contract With Customer Income Loss From Equity Method Investments And Investment Income RevenueNotFromContractWithCustomerIncomeLossFromEquityMethodInvestmentsAndInvestmentIncome	513187000	usd
CY2023Q1	step	Investments Of Consolidated Funds Cost InvestmentsOfConsolidatedFundsCost	21300000	usd
CY2022Q1	step	Investments Of Consolidated Funds Cost InvestmentsOfConsolidatedFundsCost	0	usd
CY2023Q1	step	Investments Of Consolidated Funds InvestmentsOfConsolidatedFunds	30595000	usd
CY2022Q1	step	Investments Of Consolidated Funds InvestmentsOfConsolidatedFunds	0	usd
CY2023Q1	step	Investments Of Consolidated Funds Percent Of Total Investments InvestmentsOfConsolidatedFundsPercentOfTotalInvestments	1
CY2022Q1	step	Investments Of Consolidated Funds Percent Of Total Investments InvestmentsOfConsolidatedFundsPercentOfTotalInvestments	0
CY2023	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	3000	usd
CY2023	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	9312000	usd
CY2023	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Transfers Net FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet	0	usd
CY2022	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Transfers Net FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet	0	usd
CY2023	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Net FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet	0	usd
CY2022Q1	step	Investments Of Consolidated Funds InvestmentsOfConsolidatedFunds	0	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	41713000	usd
CY2023Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	28717000	usd
CY2022Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	22040000	usd
CY2023Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	12876000	usd
CY2022Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	9278000	usd
CY2023Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	15841000	usd
CY2022Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	12762000	usd
CY2023	us-gaap	Depreciation Depreciation	4000000	usd
CY2022	us-gaap	Depreciation Depreciation	2500000	usd
CY2021	us-gaap	Depreciation Depreciation	2200000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	103544000	usd
CY2022Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	60063000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	354645000	usd
CY2022Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	398126000	usd
CY2023	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	43500000	usd
CY2022	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	24500000	usd
CY2021	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	3300000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	42645000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	41955000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	41764000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	41730000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	144838000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	354645000	usd
CY2022Q1	us-gaap	Goodwill Goodwill	580500000	usd
CY2023Q1	us-gaap	Goodwill Goodwill	580500000	usd
CY2023Q1	us-gaap	Goodwill Impaired Accumulated Impairment Loss GoodwillImpairedAccumulatedImpairmentLoss	0	usd
CY2022Q1	us-gaap	Goodwill Impaired Accumulated Impairment Loss GoodwillImpairedAccumulatedImpairmentLoss	0	usd
CY2023Q1	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	100000000	usd
CY2022Q1	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	65000000	usd
CY2023Q1	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	1649000	usd
CY2022Q1	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	2121000	usd
CY2023Q1	us-gaap	Long Term Debt LongTermDebt	98351000	usd
CY2022Q1	us-gaap	Long Term Debt LongTermDebt	62879000	usd
CY2023Q1	step	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVested	1817984	shares
CY2023Q1	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	41100000	usd
CY2023	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P3Y9M18D
CY2023	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	1800000	usd
CY2022	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	7400000	usd
CY2021	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	0	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-102560000	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	471247000	usd
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	307396000	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	61106000	usd
CY2023Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	41334000	usd
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	30453000	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-41454000	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	512581000	usd
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	337849000	usd
CY2023	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	6933000	usd
CY2022	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	13340000	usd
CY2021	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	2929000	usd
CY2023	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	1726000	usd
CY2022	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	2714000	usd
CY2021	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	1141000	usd
CY2023	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	7653000	usd
CY2023Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2022	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	6383000	usd
CY2021	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	3381000	usd
CY2023	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	16312000	usd
CY2022	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	22437000	usd
CY2021	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	7451000	usd
CY2023	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-10570000	usd
CY2022	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	4897000	usd
CY2021	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	14752000	usd
CY2023	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-1921000	usd
CY2022	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	966000	usd
CY2021	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	1074000	usd
CY2023	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	0	usd
CY2022	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	0	usd
CY2021	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	-21000	usd
CY2023	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-12491000	usd
CY2022	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	5863000	usd
CY2021	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	15805000	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	3821000	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	28300000	usd
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	23256000	usd
CY2023	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210
CY2022	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210
CY2021	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210
CY2023	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.008
CY2022	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.008
CY2021	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.006
CY2023	step	Effective Income Tax Rate Reconciliation Income Passed Through To Limited Partners Percent EffectiveIncomeTaxRateReconciliationIncomePassedThroughToLimitedPartnersPercent	0.136
CY2022	step	Effective Income Tax Rate Reconciliation Income Passed Through To Limited Partners Percent EffectiveIncomeTaxRateReconciliationIncomePassedThroughToLimitedPartnersPercent	0.119
CY2021	step	Effective Income Tax Rate Reconciliation Income Passed Through To Limited Partners Percent EffectiveIncomeTaxRateReconciliationIncomePassedThroughToLimitedPartnersPercent	0.157
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential	-0.185
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential	0.012
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential	0.010
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	0.047
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.053
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	0.000
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Prior Year Income Taxes EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes	-0.037
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Prior Year Income Taxes EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes	-0.001
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Prior Year Income Taxes EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes	0.000
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	0.001
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	-0.002
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	0.000
CY2023	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.092
CY2022	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.055
CY2021	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.069
CY2022Q1	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	26337000	usd
CY2023Q1	us-gaap	Deferred Tax Assets Investments DeferredTaxAssetsInvestments	54941000	usd
CY2022Q1	us-gaap	Deferred Tax Assets Investments DeferredTaxAssetsInvestments	39720000	usd
CY2023Q1	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	1769000	usd
CY2022Q1	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	1568000	usd
CY2023Q1	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	56710000	usd
CY2022Q1	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	41288000	usd
CY2023Q1	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	12352000	usd
CY2022Q1	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	13422000	usd
CY2023Q1	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	44358000	usd
CY2022Q1	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	27866000	usd
CY2023Q1	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	353000	usd
CY2022Q1	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	1529000	usd
CY2023Q1	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	44005000	usd
CY2023	step	Increase Decrease In Deferred Tax Assets IncreaseDecreaseInDeferredTaxAssets	6500000	usd
CY2023	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	-200000	usd
CY2021Q3	step	Increase Decrease In Due To Related Parties Tax Receivable Agreements IncreaseDecreaseInDueToRelatedPartiesTaxReceivableAgreements	8500000	usd
CY2023Q1	step	Due To Related Parties Tax Receivable Agreements DueToRelatedPartiesTaxReceivableAgreements	199300000	usd
CY2023Q1	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	12400000	usd
CY2021Q1	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	30537000	usd
CY2022	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	-27413000	usd
CY2022	step	Adjustments To Additional Paid In Capital Decrease In Deferred Tax Assets Valuation Allowance AdjustmentsToAdditionalPaidInCapitalDecreaseInDeferredTaxAssetsValuationAllowance	5006000	usd
CY2022	step	Adjustments To Additional Paid In Capital Increase In Deferred Tax Assets Valuation Allowance AdjustmentsToAdditionalPaidInCapitalIncreaseInDeferredTaxAssetsValuationAllowance	15304000	usd
CY2022Q1	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	13422000	usd
CY2023	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	-1975000	usd
CY2023	step	Adjustments To Additional Paid In Capital Increase In Deferred Tax Assets Valuation Allowance AdjustmentsToAdditionalPaidInCapitalIncreaseInDeferredTaxAssetsValuationAllowance	905000	usd
CY2023Q1	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	12352000	usd
CY2023Q1	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0	usd
CY2023Q1	us-gaap	Significant Change In Unrecognized Tax Benefits Is Reasonably Possible Amount Of Unrecorded Benefit SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit	0	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-18398000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	193885000	usd
	us-gaap	Net Income Loss NetIncomeLoss	62634000	usd
CY2023	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-18398000	usd
CY2022	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	205617000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	68411000	usd
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	61884671	shares
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	49833760	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	29657805	shares
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	61884671	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	53600250	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	33274804	shares
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.30
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	3.89
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	2.11
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.30
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	3.84
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	2.06
CY2023Q1	us-gaap	Due From Related Parties DueFromRelatedParties	54322000	usd
CY2022Q1	us-gaap	Due From Related Parties DueFromRelatedParties	19369000	usd
CY2023Q1	us-gaap	Due To Related Parties Current And Noncurrent DueToRelatedPartiesCurrentAndNoncurrent	205424000	usd
CY2022Q1	us-gaap	Due To Related Parties Current And Noncurrent DueToRelatedPartiesCurrentAndNoncurrent	199355000	usd
CY2023Q1	step	Number Of Classes Of Common Stock Outstanding NumberOfClassesOfCommonStockOutstanding	2	classofstock
CY2023Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	25000000	shares
CY2023Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2021Q1	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.07
CY2021	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.07
CY2021Q3	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.07
CY2021Q3	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.07
CY2021Q4	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.15
CY2022Q1	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.15
CY2022	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.44
CY2022Q2	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.20
CY2022Q3	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.20
CY2022Q4	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.20
CY2023Q1	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.20
CY2023	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.80
CY2022Q1	us-gaap	Redeemable Noncontrolling Interest Equity Carrying Amount RedeemableNoncontrollingInterestEquityCarryingAmount	0	usd
CY2023	us-gaap	Noncontrolling Interest Increase From Subsidiary Equity Issuance NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance	22754000	usd
CY2023	us-gaap	Net Income Loss Attributable To Redeemable Noncontrolling Interest NetIncomeLossAttributableToRedeemableNoncontrollingInterest	1776000	usd
CY2023Q1	us-gaap	Redeemable Noncontrolling Interest Equity Carrying Amount RedeemableNoncontrollingInterestEquityCarryingAmount	24530000	usd
CY2022	step	Business Acquisition Pro Forma Revenue And Unrealized Gains Losses BusinessAcquisitionProFormaRevenueAndUnrealizedGainsLosses	1866986000	usd
CY2021	step	Business Acquisition Pro Forma Revenue And Unrealized Gains Losses BusinessAcquisitionProFormaRevenueAndUnrealizedGainsLosses	1362067000	usd
CY2022	us-gaap	Business Acquisitions Pro Forma Net Income Loss BusinessAcquisitionsProFormaNetIncomeLoss	168653000	usd
CY2021	us-gaap	Business Acquisitions Pro Forma Net Income Loss BusinessAcquisitionsProFormaNetIncomeLoss	80743000	usd
CY2023	step	Lessee Operating Lease Number Of Cities LesseeOperatingLeaseNumberOfCities	25	city
CY2023	us-gaap	Operating Lease Cost OperatingLeaseCost	10983000	usd
CY2022	us-gaap	Operating Lease Cost OperatingLeaseCost	11098000	usd
CY2023	us-gaap	Variable Lease Cost VariableLeaseCost	1375000	usd
CY2022	us-gaap	Variable Lease Cost VariableLeaseCost	957000	usd
CY2023	us-gaap	Sublease Income SubleaseIncome	1778000	usd
CY2022	us-gaap	Sublease Income SubleaseIncome	1679000	usd
CY2023	us-gaap	Lease Cost LeaseCost	10580000	usd
CY2022	us-gaap	Lease Cost LeaseCost	10376000	usd
CY2023	step	Gain Loss On Remeasurement Of Lease Liabilities GainLossOnRemeasurementOfLeaseLiabilities	2700000	usd
CY2021	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	9300000	usd
CY2023	us-gaap	Operating Lease Payments OperatingLeasePayments	10613000	usd
CY2022	us-gaap	Operating Lease Payments OperatingLeasePayments	10319000	usd
CY2023Q1	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P12Y1M6D
CY2022Q1	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P7Y8M12D
CY2023Q1	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.046
CY2022Q1	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.027
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	12337000	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	14062000	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	15179000	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	14362000	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	12474000	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	96504000	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	164918000	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	43694000	usd
CY2023Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	121224000	usd
CY2023Q1	us-gaap	Off Balance Sheet Credit Loss Liability OffBalanceSheetCreditLossLiability	88700000	usd
CY2022Q1	us-gaap	Off Balance Sheet Credit Loss Liability OffBalanceSheetCreditLossLiability	68200000	usd
CY2023Q1	us-gaap	Off Balance Sheet Credit Loss Liability OffBalanceSheetCreditLossLiability	88700000	usd
CY2022Q1	us-gaap	Off Balance Sheet Credit Loss Liability OffBalanceSheetCreditLossLiability	68200000	usd
CY2023Q1	step	Equity Method Investment Carried Interest Allocations Maximum Amount Subject To Contingent Repayment EquityMethodInvestmentCarriedInterestAllocationsMaximumAmountSubjectToContingentRepayment	264100000	usd
CY2023	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	4600000	usd
CY2022	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	4300000	usd
CY2021	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	3200000	usd
CY2023Q1	us-gaap	Defined Benefit Plan Fair Value Of Plan Assets DefinedBenefitPlanFairValueOfPlanAssets	27400000	usd
CY2022Q1	us-gaap	Defined Benefit Plan Fair Value Of Plan Assets DefinedBenefitPlanFairValueOfPlanAssets	23800000	usd
CY2023Q1	us-gaap	Defined Benefit Plan Funded Status Of Plan DefinedBenefitPlanFundedStatusOfPlan	-2800000	usd
CY2022Q1	us-gaap	Defined Benefit Plan Funded Status Of Plan DefinedBenefitPlanFundedStatusOfPlan	-2200000	usd
CY2023	us-gaap	Defined Benefit Plan Net Periodic Benefit Cost DefinedBenefitPlanNetPeriodicBenefitCost	500000	usd
CY2022	us-gaap	Defined Benefit Plan Net Periodic Benefit Cost DefinedBenefitPlanNetPeriodicBenefitCost	1100000	usd
CY2021	us-gaap	Defined Benefit Plan Net Periodic Benefit Cost DefinedBenefitPlanNetPeriodicBenefitCost	900000	usd

Files In Submission

Name	View Source	Status
FilingSummary.xml	Edgar Link	unprocessable
0001796022-23-000033-index-headers.html	Edgar Link	pending
0001796022-23-000033-index.html	Edgar Link	pending
0001796022-23-000033.txt	Edgar Link	pending
0001796022-23-000033-xbrl.zip	Edgar Link	pending
exhibit1012-conformedcre.htm	Edgar Link	pending
exhibit1012-conformedcre001.jpg	Edgar Link	pending
exhibit1012-conformedcre002.jpg	Edgar Link	pending
exhibit1012-conformedcre003.jpg	Edgar Link	pending
exhibit1012-conformedcre004.jpg	Edgar Link	pending
exhibit1012-conformedcre005.jpg	Edgar Link	pending
exhibit1012-conformedcre006.jpg	Edgar Link	pending
exhibit1012-conformedcre007.jpg	Edgar Link	pending
exhibit1012-conformedcre008.jpg	Edgar Link	pending
exhibit1012-conformedcre009.jpg	Edgar Link	pending
exhibit1012-conformedcre010.jpg	Edgar Link	pending
exhibit1012-conformedcre011.jpg	Edgar Link	pending
exhibit1012-conformedcre012.jpg	Edgar Link	pending
exhibit1012-conformedcre013.jpg	Edgar Link	pending
exhibit1012-conformedcre014.jpg	Edgar Link	pending
exhibit1012-conformedcre015.jpg	Edgar Link	pending
exhibit1012-conformedcre016.jpg	Edgar Link	pending
exhibit1012-conformedcre017.jpg	Edgar Link	pending
exhibit1012-conformedcre018.jpg	Edgar Link	pending
exhibit1012-conformedcre019.jpg	Edgar Link	pending
exhibit1012-conformedcre020.jpg	Edgar Link	pending
exhibit1012-conformedcre021.jpg	Edgar Link	pending
exhibit1012-conformedcre022.jpg	Edgar Link	pending
exhibit1012-conformedcre023.jpg	Edgar Link	pending
exhibit1012-conformedcre024.jpg	Edgar Link	pending
exhibit1012-conformedcre025.jpg	Edgar Link	pending
exhibit1012-conformedcre026.jpg	Edgar Link	pending
exhibit1012-conformedcre027.jpg	Edgar Link	pending
exhibit1012-conformedcre028.jpg	Edgar Link	pending
exhibit1012-conformedcre029.jpg	Edgar Link	pending
exhibit1012-conformedcre030.jpg	Edgar Link	pending
exhibit1012-conformedcre031.jpg	Edgar Link	pending
exhibit1012-conformedcre032.jpg	Edgar Link	pending
exhibit1012-conformedcre033.jpg	Edgar Link	pending
exhibit1012-conformedcre034.jpg	Edgar Link	pending
exhibit1012-conformedcre035.jpg	Edgar Link	pending
exhibit1012-conformedcre036.jpg	Edgar Link	pending
exhibit1012-conformedcre037.jpg	Edgar Link	pending
exhibit1012-conformedcre038.jpg	Edgar Link	pending
exhibit1012-conformedcre039.jpg	Edgar Link	pending
exhibit1012-conformedcre040.jpg	Edgar Link	pending
exhibit1012-conformedcre041.jpg	Edgar Link	pending
exhibit1012-conformedcre042.jpg	Edgar Link	pending
exhibit1012-conformedcre043.jpg	Edgar Link	pending
exhibit1012-conformedcre044.jpg	Edgar Link	pending
exhibit1012-conformedcre045.jpg	Edgar Link	pending
exhibit1012-conformedcre046.jpg	Edgar Link	pending
exhibit1012-conformedcre047.jpg	Edgar Link	pending
exhibit1012-conformedcre048.jpg	Edgar Link	pending
exhibit1012-conformedcre049.jpg	Edgar Link	pending
exhibit1012-conformedcre050.jpg	Edgar Link	pending
exhibit1012-conformedcre051.jpg	Edgar Link	pending
exhibit1012-conformedcre052.jpg	Edgar Link	pending
exhibit1012-conformedcre053.jpg	Edgar Link	pending
exhibit1012-conformedcre054.jpg	Edgar Link	pending
exhibit1012-conformedcre055.jpg	Edgar Link	pending
exhibit1012-conformedcre056.jpg	Edgar Link	pending
exhibit1012-conformedcre057.jpg	Edgar Link	pending
exhibit1012-conformedcre058.jpg	Edgar Link	pending
exhibit1012-conformedcre059.jpg	Edgar Link	pending
exhibit1012-conformedcre060.jpg	Edgar Link	pending
exhibit1012-conformedcre061.jpg	Edgar Link	pending
exhibit1012-conformedcre062.jpg	Edgar Link	pending
exhibit1012-conformedcre063.jpg	Edgar Link	pending
exhibit1012-conformedcre064.jpg	Edgar Link	pending
exhibit1012-conformedcre065.jpg	Edgar Link	pending
exhibit1012-conformedcre066.jpg	Edgar Link	pending
exhibit1012-conformedcre067.jpg	Edgar Link	pending
exhibit1012-conformedcre068.jpg	Edgar Link	pending
exhibit1012-conformedcre069.jpg	Edgar Link	pending
exhibit1012-conformedcre070.jpg	Edgar Link	pending
exhibit1012-conformedcre071.jpg	Edgar Link	pending
exhibit1012-conformedcre072.jpg	Edgar Link	pending
exhibit1012-conformedcre073.jpg	Edgar Link	pending
exhibit1012-conformedcre074.jpg	Edgar Link	pending
exhibit1012-conformedcre075.jpg	Edgar Link	pending
exhibit1012-conformedcre076.jpg	Edgar Link	pending
exhibit1012-conformedcre077.jpg	Edgar Link	pending
exhibit1012-conformedcre078.jpg	Edgar Link	pending
exhibit1012-conformedcre079.jpg	Edgar Link	pending
exhibit1012-conformedcre080.jpg	Edgar Link	pending
exhibit1012-conformedcre081.jpg	Edgar Link	pending
exhibit1012-conformedcre082.jpg	Edgar Link	pending
exhibit1012-conformedcre083.jpg	Edgar Link	pending
exhibit1012-conformedcre084.jpg	Edgar Link	pending
exhibit1012-conformedcre085.jpg	Edgar Link	pending
exhibit1012-conformedcre086.jpg	Edgar Link	pending
exhibit1012-conformedcre087.jpg	Edgar Link	pending
exhibit1012-conformedcre088.jpg	Edgar Link	pending
exhibit1012-conformedcre089.jpg	Edgar Link	pending
exhibit1012-conformedcre090.jpg	Edgar Link	pending
exhibit1012-conformedcre091.jpg	Edgar Link	pending
exhibit1012-conformedcre092.jpg	Edgar Link	pending
exhibit1012-conformedcre093.jpg	Edgar Link	pending
exhibit1012-conformedcre094.jpg	Edgar Link	pending
exhibit1012-conformedcre095.jpg	Edgar Link	pending
exhibit1012-conformedcre096.jpg	Edgar Link	pending
exhibit1012-conformedcre097.jpg	Edgar Link	pending
exhibit1012-conformedcre098.jpg	Edgar Link	pending
exhibit1012-conformedcre099.jpg	Edgar Link	pending
exhibit1012-conformedcre100.jpg	Edgar Link	pending
exhibit1012-conformedcre101.jpg	Edgar Link	pending
exhibit1012-conformedcre102.jpg	Edgar Link	pending
exhibit1012-conformedcre103.jpg	Edgar Link	pending
exhibit1012-conformedcre104.jpg	Edgar Link	pending
exhibit1012-conformedcre105.jpg	Edgar Link	pending
exhibit1012-conformedcre106.jpg	Edgar Link	pending
exhibit1012-conformedcre107.jpg	Edgar Link	pending
exhibit1012-conformedcre108.jpg	Edgar Link	pending
exhibit1012-conformedcre109.jpg	Edgar Link	pending
exhibit1012-conformedcre110.jpg	Edgar Link	pending
exhibit1012-conformedcre111.jpg	Edgar Link	pending
exhibit1012-conformedcre112.jpg	Edgar Link	pending
exhibit1012-conformedcre113.jpg	Edgar Link	pending
exhibit1012-conformedcre114.jpg	Edgar Link	pending
exhibit1012-conformedcre115.jpg	Edgar Link	pending
exhibit1012-conformedcre116.jpg	Edgar Link	pending
exhibit1012-conformedcre117.jpg	Edgar Link	pending
exhibit1012-conformedcre118.jpg	Edgar Link	pending
exhibit1012-conformedcre119.jpg	Edgar Link	pending
exhibit1012-conformedcre120.jpg	Edgar Link	pending
exhibit1012-conformedcre121.jpg	Edgar Link	pending
exhibit1012-conformedcre122.jpg	Edgar Link	pending
exhibit1012-conformedcre123.jpg	Edgar Link	pending
exhibit1012-conformedcre124.jpg	Edgar Link	pending
exhibit1012-conformedcre125.jpg	Edgar Link	pending
exhibit1012-conformedcre126.jpg	Edgar Link	pending
exhibit1012-conformedcre127.jpg	Edgar Link	pending
exhibit1012-conformedcre128.jpg	Edgar Link	pending
exhibit1012-conformedcre129.jpg	Edgar Link	pending
exhibit1012-conformedcre130.jpg	Edgar Link	pending
exhibit1012-conformedcre131.jpg	Edgar Link	pending
exhibit1012-conformedcre132.jpg	Edgar Link	pending
exhibit1012-conformedcre133.jpg	Edgar Link	pending
exhibit1012-conformedcre134.jpg	Edgar Link	pending
exhibit1012-conformedcre135.jpg	Edgar Link	pending
exhibit1012-conformedcre136.jpg	Edgar Link	pending
exhibit1012-conformedcre137.jpg	Edgar Link	pending
exhibit1012-conformedcre138.jpg	Edgar Link	pending
exhibit1012-conformedcre139.jpg	Edgar Link	pending
exhibit1012-conformedcre140.jpg	Edgar Link	pending
exhibit1012-conformedcre141.jpg	Edgar Link	pending
exhibit1012-conformedcre142.jpg	Edgar Link	pending
exhibit1012-conformedcre143.jpg	Edgar Link	pending
exhibit1012-conformedcre144.jpg	Edgar Link	pending
exhibit1012-conformedcre145.jpg	Edgar Link	pending
exhibit1012-conformedcre146.jpg	Edgar Link	pending
exhibit1012-conformedcre147.jpg	Edgar Link	pending
exhibit211-subsidiarieslis.htm	Edgar Link	pending
exhibit231consentofeyq4fy2.htm	Edgar Link	pending
exhibit311q4fy2023.htm	Edgar Link	pending
exhibit312q4fy2023.htm	Edgar Link	pending
exhibit321q4fy2023.htm	Edgar Link	pending
exhibit322q4fy2023.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R86.htm	Edgar Link	pending
R87.htm	Edgar Link	pending
R88.htm	Edgar Link	pending
R89.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
R90.htm	Edgar Link	pending
R9999.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
step-20230331.htm	Edgar Link	pending
step-20230331.xsd	Edgar Link	pending
step-20230331_g1.jpg	Edgar Link	pending
step-20230331_g2.jpg	Edgar Link	pending
step-20230331_g3.jpg	Edgar Link	pending
step-20230331_def.xml	Edgar Link	unprocessable
step-20230331_lab.xml	Edgar Link	unprocessable
step-20230331_pre.xml	Edgar Link	unprocessable
step-20230331_cal.xml	Edgar Link	unprocessable
step-20230331_htm.xml	Edgar Link	completed

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$STEP
StepStone Group Inc. Stock $step

2023 Q1 Form 10-K Financial Statement

#000179602223000033 Filed on May 26, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$STEP StepStone Group Inc. Stock $step

2023 Q1 Form 10-K Financial Statement

#000179602223000033 Filed on May 26, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$STEP
StepStone Group Inc. Stock $step